We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+13.29%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.5B
AUM Growth
+$748M
Cap. Flow
+$681M
Cap. Flow %
45.46%
Top 10 Hldgs %
71.8%
Holding
659
New
195
Increased
97
Reduced
113
Closed
226

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$21.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$17M
3
AVGO icon
Broadcom
AVGO
+$16.6M
4
MRVL icon
Marvell Technology
MRVL
+$14.3M
5
TMUS icon
T-Mobile US
TMUS
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.98%
2 Technology 3.97%
3 Financials 3.94%
4 Consumer Discretionary 2.88%
5 Industrials 1.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAT icon
401
CALL
Nordic American Tanker
NAT
$1.33B
$153K 0.01%
+50,000
New +$161K
BCOV
402
DELISTED
Brightcove, Inc.
BCOV
$153K 0.01%
29,246
MTRX icon
403
Matrix Service
MTRX
$326M
$151K 0.01%
24,221
PR
404
Permian Resources
PR
$17.8B
$148K 0.01%
15,793
-36,972
-70% -$354K
TBCH
405
Turtle Beach Corp
TBCH
$251M
$148K 0.01%
20,594
SBRA icon
406
Sabra Healthcare REIT
SBRA
$5.28B
$143K 0.01%
+11,531
New +$147K
CDXS icon
407
Codexis
CDXS
$161M
$136K 0.01%
+29,121
New +$160K
TG icon
408
Tredegar Corp
TG
$292M
$132K 0.01%
12,953
-2,757
-18% -$28.8K
SFIX
409
Stitch Fix
SFIX
$530M
$129K 0.01%
+41,639
New +$156K
EDIT icon
410
Editas Medicine
EDIT
$432M
$127K 0.01%
+14,333
New +$157K
SPRY icon
411
ARS Pharmaceuticals
SPRY
$587M
$127K 0.01%
+14,832
New +$96.2K
LL
412
DELISTED
LL Flooring Holdings, Inc.
LL
$126K 0.01%
+22,349
New +$157K
WTTR icon
413
Select Water Solutions
WTTR
$2.69B
$123K 0.01%
+13,345
New +$112K
FLWS icon
414
1-800-Flowers.com
FLWS
$255M
$120K 0.01%
12,567
-115,122
-90% -$914K
TDS icon
415
Telephone and Data Systems
TDS
$3.84B
$119K 0.01%
11,310
-40,855
-78% -$506K
PGEN icon
416
Precigen
PGEN
$2.51B
$118K 0.01%
+77,955
New +$134K
AMRN
417
Amarin Corp
AMRN
$298M
$116K 0.01%
4,783
+2,181
+84% +$52.4K
AFMD
418
DELISTED
Affimed
AFMD
$110K 0.01%
8,907
+825
+10% +$14.5K
RNAC icon
419
Cartesian Therapeutics
RNAC
$265M
$110K 0.01%
3,240
GTHX
420
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$98.2K 0.01%
+18,093
New +$152K
AMPS
421
DELISTED
Altus Power
AMPS
$96.4K 0.01%
+14,789
New +$121K
TUYA
422
Tuya Inc
TUYA
$1.13B
$94.2K 0.01%
+49,324
New +$59.9K
SPNE
423
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$93.5K 0.01%
+11,200
New +$75.4K
GRNT icon
424
Granite Ridge Resources
GRNT
$670M
$90.3K 0.01%
+10,000
New +$90.3K
LXRX icon
425
Lexicon Pharmaceuticals
LXRX
$1.07B
$88.4K 0.01%
46,281
-8,500
-16% -$18.1K

Similar funds

Caxton Associates (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Caxton Associates (New York) held 659 positions worth $1.5B, up 100% from $751M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Caxton Associates (New York) deployed $681M of net new capital in Q4 2022, opening 195 new positions and adding to 97 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,356,392 shares worth $519M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Amazon, an estimated $21.3M trimmed.

  • Caxton Associates (New York)'s largest Q4 2022 buy was State Street SPDR S&P 500 ETF Trust: 1,356,392 shares worth $519M.
  • Caxton Associates (New York) added most to Visa in Q4 2022, an estimated $13M increase.
  • Caxton Associates (New York)'s biggest Q4 2022 reduction was Amazon, cutting an estimated $21.3M.
  • Caxton Associates (New York) fully exited Broadcom in Q4 2022, selling an estimated $16.6M.
  • Caxton Associates (New York)'s ten largest holdings make up 72% of its $1.5B portfolio in Q4 2022.
  • Caxton Associates (New York) opened 195 new positions and closed 226 in Q4 2022.
  • Caxton Associates (New York)'s portfolio value rose 100% quarter-over-quarter to $1.5B.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.